What are the long-term effects of TRT — is it safe to take indefinitely?

Long-term TRT (beyond 10 years) has limited RCT data but substantial observational data, the most clinically meaningful long-term concerns are: (1) persistent HPG axis suppression making natural testosterone production unlikely to resume if TRT is stopped; (2) cumulative polycythemia risk requiring ongoing hematocrit management; (3) prostate size increase (though not prostate cancer risk increase in current evidence); (4) potential for cardiovascular effects not captured in 3-year trials, the TRAVERSE trial ran 33 months, not 10 years (Bhasin et al., J Clin Endocrinol Metab, 2010).

The honest answer to "is TRT safe indefinitely" is: we have 3-year RCT data and 10–20-year observational data suggesting acceptable safety in appropriately monitored men, but we do not have 20-year RCT data, and the men currently receiving indefinite TRT are doing so with incomplete long-term evidence. This does not mean TRT is unsafe long-term, it means the evidence horizon for indefinite use is limited, and the appropriate clinical response is continued monitoring, not indefinite maintenance without reassessment.

Honesty Scale: Promising (2) for long-term TRT safety in appropriately monitored men based on available evidence.

What to do: Re-evaluate TRT indication and risk-benefit balance annually with your physician. Annual review should include: symptom burden assessment, current testosterone level, hematocrit, PSA trend, blood pressure, and a discussion of whether dose optimization is needed.

For the full picture, read The Testosterone/TRT Deep Dive